The modern molecular classifications support the important roles of signaling pathways like EGFR/HER2, p53, PI3K, immune checkpoint pathways, and cell adhesion signaling molecules in GC tumorigenesis, progression, metastasis, and therapeutic responsiveness. This evidence concerns the gene TP53 and gastric cancer.